|
1
|
Jemal A, Siegel R, Ward E, Hao Y, Xu Y,
Murray T and Thun MJ: Cancer statistics, 2008. CA Cancer J Clin.
58:71–96. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pisters KM and Darling G: The IASLC lung
cancer staging project: ‘The Nodal Zone’. J Thorac Oncol.
2:583–584. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Weidner N: Intratumor microvessel density
as a prognostic factor in cancer. Am J Pathol. 147:9–19.
1995.PubMed/NCBI
|
|
4
|
Folkman J: The role of angiogenesis in
tumor growth. Semin Cancer Biol. 3:65–71. 1992.PubMed/NCBI
|
|
5
|
Cox G, Jones JL, Walker RA, Steward WP and
O'Byrne KJ: Angiogenesis and non-small cell lung cancer. Lung
Cancer. 27:81–100. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fox SB, Gatter KC and Harris AL: Tumour
angiogenesis. J Pathol. 179:232–237. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mineo TC, Ambrogi V, Baldi A, Rabitti C,
Bollero P, Vincenzi B and Tonin G: Prognostic impact of VEGF, CD31,
CD34, and CD105 expression and tumour vessel invasion after radical
surgery for IB-IIA non-small cell lung cancer. J Clin Pathol.
57:591–597. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Abu-Jawdeh GM, Faix JD, Niloff J, Tognazzi
K, Manseau E, Dvorak HF and Brown LF: Strong expression of vascular
permeability factor (vascular endothelial growth factor) and its
receptors in ovarian borderline and malignant neoplasms. Lab
Invest. 74:1105–1115. 1996.PubMed/NCBI
|
|
9
|
Claffey KP, Brown LF, del Aguila LF,
Tognazzi K, Yeo KT, Manseau EJ and Dvorak HF: Expression of
vascular permeability factor/vascular endothelial growth factor by
melanoma cells increases tumor growth, angiogenesis, and
experimental metastasis. Cancer Res. 56:172–181. 1996.PubMed/NCBI
|
|
10
|
Maeda K, Chung YS, Ogawa Y, Takatsuka S,
Kang SM, Ogawa M, Sawada T and Sowa M: Prognostic value of vascular
endothelial growth factor expression in gastric carcinoma. Cancer.
77:858–863. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Takahashi Y, Kitadai Y, Bucana CD, Cleary
KR and Ellis LM: Expression of vascular endothelial growth factor
and its receptor, KDR, correlates with vascularity, metastasis, and
proliferation of human colon cancer. Cancer Res. 55:3964–3968.
1995.PubMed/NCBI
|
|
12
|
Maharaj AS, Saint-Geniez M, Maldonado AE
and D'Amore PA: Vascular endothelial growth factor localization in
the adult. Am J Pathol. 168:639–648. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ferrera N: Vascular endothelial growth
factor. Trends Cardiovasc Med. 3:244–250. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Meert AP, Paesmans M, Martin B, Delmotte
P, Berghmans T, Verdebout JM, Lafitte JJ, Mascaux C and Sculier JP:
The role of microvessel density on the survival of patients with
lung cancer: A systematic review of the literature with
meta-analysis. Br J Cancer. 87:694–701. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kadota K, Huang CL, Liu D, Ueno M, Kushida
Y, Haba R and Yokomise H: The clinical significance of
lymphangiogenesis and angiogenesis in non-small cell lung cancer
patients. Eur J Cancer. 44:1057–1067. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fontanini G, Vignati S, Boldrini L, Chinè
S, Silvestri V, Lucchi M, Mussi A, Angeletti CA and Bevilacqua G:
Vascular endothelial growth factor is associated with
neovascularization and influences progression of non-small cell
lung carcinoma. Clin Cancer Res. 3:861–865. 1997.PubMed/NCBI
|
|
17
|
Han H, Silverman JF, Santucci TS, Macherey
RS, d'Amato TA, Tung MY, Weyant RJ and Landreneau RJ: Vascular
endothelial growth factor expression in stage I non-small cell lung
cancer correlates with neoangiogenesis and a poor prognosis. Ann
Surg Oncol. 8:72–79. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
International Association for the Study of
Lung Cancer and Peter GoldstrawIASLC Staging Manual in Thoracic
Oncology. Orange Park: Editorial Rx Press; 2009
|
|
19
|
Janković M, Samarzija M, Jakopović M,
Kulis T and Znaor A: Trends in lung cancer incidence and mortality
in Croatia, 1988–2008. Croat Med J. 53:93–99. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Matsuyama K, Chiba Y, Sasaki M, Tanaka H,
Muraoka R and Tanigawa N: Tumor angiogenesis as a prognostic marker
in operable non-small cell lung cancer. Ann Thorac Surg.
65:1405–1409. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Macchiarini P, Fontanini G, Hardin MJ,
Squartini F and Angeletti CA: Relation of neovascularization to
metastasis of non-small cell lung cancer. Lancet. 340:145–146.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Giatromanolaki A, Koukourakis MI,
Theodossiou D, Barbatis K, O'Byrne K, Harris AL and Gatter KC:
Comparative evaluation of angiogenesis assessment with
anti-factor-VIII and anti-CD31 immunostaining in non-small cell
lung cancer. Clin Cancer Res. 3:2485–9224. 1997.PubMed/NCBI
|
|
23
|
Angeletti CA, Lucchi M, Fontanini G, Mussi
A, Chella A, Ribechini A, Vignati S and Bevilacqua G: Prognostic
significance of tumoral angiogenesis in completely resected late
stage lung carcinoma (stage IIIA-N2). Impact of adjuvant therapies
in a subset of patients at high risk of recurrence. Cancer.
78:409–415. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chandrachud LM, Pendleton N, Chisholm DM,
Horan MA and Schor AM: Relationship between vascularity, age and
survival in non-small-cell lung cancer. Br J Cancer. 76:1367–1375.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pastorino U, Andreola S, Tagliabue E,
Pezzella F, Incarbone M, Sozzi G, Buyse M, Menard S, Pierotti M and
Rilke F: Immunocytochemical markers in stage I lung cancer:
Relevance to prognosis. J Clin Oncol. 15:2858–2865. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Imoto H, Osaki T, Taga S, Ohgami A,
Ichiyoshi Y and Yasumoto K: Vascular endothelial growth factor
expression in non-small-cell lung cancer: Prognostic significance
in squamous cell carcinoma. J Thorac Cardiovasc Surg.
115:1007–1014. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Iwasaki A, Kuwahara M, Yoshinaga Y and
Shirakusa T: Basic fibroblast growth factor (bFGF) and vascular
endothelial growth factor (VEGF) levels, as prognostic indicators
in NSCLC. Eu J Cardio-Thoracic Surg. 25:443–448. 2004. View Article : Google Scholar
|
|
28
|
Bonnesen B, Pappot H, Holmstav J and Skov
BG: Vascular endothelial growth factor A and vascular endothelial
growth factor receptor 2 expression in non-small cell lung cancer
patients: Relation to prognosis. Lung Cancer. 66:314–318. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yano T, Tanikawa S, Fujie T, Masutani M
and Horie T: Vascular endothelial growth factor expression and
neovascularisation in non-small cell lung cancer. Eur J Cancer.
36:601–609. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Decaussin M, Sartelet H, Robert C, Moro D,
Claraz C, Brambilla C and Brambilla E: Expression of vascular
endothelial growth factor (VEGF) and its two receptors
(VEGF-R1-Flt1 and VEGF-R2-Flk1/KDR) in non-small cell lung
carcinomas (NSCLCs): Correlation with angiogenesis and survival. J
Pathol. 188:369–377. 1999. View Article : Google Scholar : PubMed/NCBI
|
